Stocks analysis

ABT vs ADI Stock Comparison

Scores Breakdown

Metric ABT ADI
📈 Growth 22/30 28/30
💰 Profitability 17/20 18/20
🏦 Financial Health 15/20 19/20
💵 Valuation 12/20 12/20
⚠️ Risk (lower is better) 4/10 4/10
Overall Score 72/100 83/100

Side-by-Side Summaries

ABT Analysis ADI Analysis

📈 Growth & Financial Trajectory

Over the 8-quarter window, Revenue gravitated around $9.96B to $11.16B, ending at $11.16B in 2026 Q1, a start-to-end rise of about $1.2B (~12%). Net income remained positive through most quarters, with modest-to-strong fluctuations; several quarters show mid-single-digit billions in income, with notable variability from one-off items (e.g., tax effects).

💰 Margins & Cash Flow

Gross Margin was solid, around 56% on average (Gross Profit ~6.3B vs Revenues ~11.2B in 2026 Q1). Operating margin ranged roughly from 12% to 18%, peaking in 2025 Q2. Net cash flow from operating activities was consistently positive (e.g., 2026 Q1: $1.315B; prior quarters in the 1.4–2.9B range), while investing activities were typically cash outflows and financing modest.

🛡️ Balance Sheet & Liquidity

Total assets approximate $72B–$110B over the period with equity in the low-to-mid $50B range. The company shows a healthy current ratio (1.3–1.5) and modest long-term debt ($14–19B), supporting liquidity and balance sheet resilience.

⚠️ Key Drivers & Risks

  • Drivers: (1) Pharma/medical devices demand; (2) diversified product mix and recurring revenue from Rx/OTC portfolios.
  • Risks: (1) Regulatory/tax volatility and pricing pressure; (2) macro-cycle sensitivity and currency exposure.

📈 Growth & Financial Trajectory

Across eight quarters from 2024 Q3 to 2026 Q2, ANALOG DEVICES INC shows a steady top-line expansion: Revenues rise from about $2.31B to $3.62B, a ~56% gain. Net income climbs from ~$392M to ~$1,176M, up ~200%, signaling improving operating leverage as volumes scale. The trend is predominantly upward, with performance stepping higher into 2025–2026, culminating in a strong Q2 2026 print.

💰 Margins & Cash Flow

Gross margin remains robust in the mid-50s to mid-60s percent range, supported by mix and pricing. Operating leverage improves as fixed costs amortize with volume. Operating cash flow is consistently positive; Net cash flow fluctuates due to financing activities, with Q2 2026 showing a negative quarterly net cash flow despite solid operating cash generation. Investing cash flow is modestly negative, while financing activity fluctuations drive quarterly cash flow swings.

🛡️ Balance Sheet & Liquidity

Equity attributable to parent sits around the low-$30B level; Liabilities total roughly mid-$14B, with current assets near $5–7B and current liabilities around $3–4B, giving a healthy current ratio and ample liquidity cushion. The balance sheet shows strong equity, manageable leverage, and a solid asset base.

⚠️ Key Drivers & Risks

  • Drivers: AI/data-center demand; automotive and industrial sensors.
  • Risks: Semiconductor cyclicality; macro shifts and valuation sensitivity.